mitomycin has been researched along with Lymphangitis in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Lymphangitis: A lymphatic disease characterized by INFLAMMATION of LYMPHATIC VESSELS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oyama, K | 1 |
| Fushida, S | 1 |
| Taniguchi, K | 1 |
| Bando, E | 1 |
| Fujita, H | 1 |
| Michiwa, Y | 1 |
| Fujimura, T | 1 |
| Nishimura, G | 1 |
| Yonemura, Y | 1 |
| Miwa, K | 1 |
1 other study available for mitomycin and Lymphangitis
| Article | Year |
|---|---|
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1999 |